Understanding how the SARS-CoV-2 virus replicates and how to inhibit it
Structure, function, and inhibition of the SARS-CoV-2 replication-transcription complex
This study is looking at how the COVID-19 virus makes copies of itself, focusing on a special enzyme that could help us find new ways to treat the virus, which might lead to better medicines for people with COVID-19.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rockefeller University NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11177102 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which the SARS-CoV-2 virus replicates its RNA genome, focusing on a key enzyme called RNA-dependent RNA polymerase (RdRp). By analyzing the structure of this enzyme and its interactions with other viral proteins, the research aims to identify potential targets for new antiviral treatments. The study will utilize advanced techniques to visualize these molecular structures, which could lead to the development of more effective antiviral agents. Patients may benefit from this research as it could contribute to the creation of new therapies for COVID-19.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by COVID-19 or those at high risk of severe illness from the virus.
Not a fit: Patients who are not infected with SARS-CoV-2 or those who have already recovered from COVID-19 may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antiviral treatments for COVID-19, potentially improving patient outcomes.
How similar studies have performed: Previous research has shown success in targeting viral replication mechanisms, indicating that this approach has the potential for significant breakthroughs.
Where this research is happening
New York, United States
- Rockefeller University — New York, United States (Active)
Researchers
- Principal investigator: Darst, Seth a. — Rockefeller University
- Study coordinator: Darst, Seth a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.